Mega Genomics Statistics

Total Valuation

Mega Genomics has a market cap or net worth of HKD 1.61 billion. The enterprise value is 1.11 billion.

Market Cap	1.61B
Enterprise Value	1.11B

Important Dates

The next estimated earnings date is Friday, May 30, 2025.

Earnings Date	May 30, 2025
Ex-Dividend Date	n/a

Share Statistics

Mega Genomics has 224.30 million shares outstanding. The number of shares has decreased by -4.83% in one year.

Current Share Class	224.30M
Shares Outstanding	224.30M
Shares Change (YoY)	-4.83%
Shares Change (QoQ)	+3.53%
Owned by Insiders (%)	22.89%
Owned by Institutions (%)	0.01%
Float	115.89M

Valuation Ratios

The trailing PE ratio is 43.30.

PE Ratio	43.30
Forward PE	n/a
PS Ratio	9.41
PB Ratio	2.27
P/TBV Ratio	2.27
P/FCF Ratio	17.17
P/OCF Ratio	13.50
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 22.23, with an EV/FCF ratio of 11.83.

EV / Earnings	32.47
EV / Sales	6.48
EV / EBITDA	22.23
EV / EBIT	32.35
EV / FCF	11.83

Financial Position

The company has a current ratio of 5.43, with a Debt / Equity ratio of 0.06.

Current Ratio	5.43
Quick Ratio	5.03
Debt / Equity	0.06
Debt / EBITDA	0.89
Debt / FCF	0.47
Interest Coverage	17.85

Financial Efficiency

Return on equity (ROE) is 4.83% and return on invested capital (ROIC) is 2.92%.

Return on Equity (ROE)	4.83%
Return on Assets (ROA)	2.55%
Return on Invested Capital (ROIC)	2.92%
Return on Capital Employed (ROCE)	4.57%
Revenue Per Employee	801,916
Profits Per Employee	160,120
Employee Count	229
Asset Turnover	0.20
Inventory Turnover	30.13

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -20.88% in the last 52 weeks. The beta is 1.02, so Mega Genomics's price volatility has been similar to the market average.

Beta (5Y)	1.02
52-Week Price Change	-20.88%
50-Day Moving Average	7.35
200-Day Moving Average	8.27
Relative Strength Index (RSI)	46.97
Average Volume (20 Days)	5,480

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Mega Genomics had revenue of HKD 171.61 million and earned 34.27 million in profits. Earnings per share was 0.17.

Revenue	171.61M
Gross Profit	99.51M
Operating Income	34.39M
Pretax Income	39.67M
Net Income	34.27M
EBITDA	42.98M
EBIT	34.39M
Earnings Per Share (EPS)	0.17

Full Income Statement

Balance Sheet

The company has 546.85 million in cash and 44.51 million in debt, giving a net cash position of 502.34 million or 2.24 per share.

Cash & Cash Equivalents	546.85M
Total Debt	44.51M
Net Cash	502.34M
Net Cash Per Share	2.24
Equity (Book Value)	712.00M
Book Value Per Share	3.02
Working Capital	623.13M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 119.63 million and capital expenditures -25.58 million, giving a free cash flow of 94.05 million.

Operating Cash Flow	119.63M
Capital Expenditures	-25.58M
Free Cash Flow	94.05M
FCF Per Share	0.42

Full Cash Flow Statement

Margins

Gross margin is 57.99%, with operating and profit margins of 20.04% and 19.97%.

Gross Margin	57.99%
Operating Margin	20.04%
Pretax Margin	23.12%
Profit Margin	19.97%
EBITDA Margin	25.05%
EBIT Margin	20.04%
FCF Margin	54.81%

Dividends & Yields

Mega Genomics does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	4.83%
Shareholder Yield	n/a
Earnings Yield	2.12%
FCF Yield	5.82%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Mega Genomics has an Altman Z-Score of 8.58.

Altman Z-Score	8.58
Piotroski F-Score	n/a